Streetbeat News

Stock Prices

SPHR

Sphere Entertainment shares are trading higher following a Q4 revenue beat.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:33 am

VRCA

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) announced positive preliminary results from Part 2 of its Phase 2 clinical trial for VP-315, a potential first-in-class oncolytic peptide for treating basal cell carcinoma. The trial showed a 51% complete histological clearance of tumors and an 86% overall reduction in tumor size. No dose-limiting toxicities or serious adverse events were reported. The company plans to request an End-of-Phase 2 meeting with the FDA in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:32 am

BKKT

Bakkt has lowered its FY24 crypto revenue guidance from $3.00B-4.45B to $2.57B-2.83B. The company expects net loyalty revenues of $53M–$57M and gross crypto revenues of $2.515B-$2.770B. Operating expenses excluding certain costs are projected to be $157M-$162M. Net cash used in operating activities is expected to be ($72M)–($79M), with free cash flow usage of ($79M)–($86M). End-of-year available cash is projected to be $35M–$42M.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:31 am

VSCO

Victoria's Secret has announced its preliminary Q2 adjusted EPS to be between $0.34 and $0.39, significantly higher than the estimated $0.15 and the prior outlook of $0.05 to $0.20. The company also updated its net sales growth to a range of -1% to -2%, compared to the previous guidance of -1% to -3%.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:31 am

ALBT

Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC, in which Avalon holds a 40% interest, has begun manufacturing the GeeWhiz External Condom Catheter, an FDA-registered male incontinence device. The product is set to launch in Q3 2024. The global male urinary incontinence market is expected to grow significantly. Avalon has also launched a DNA test for opioid dependence and extended a distribution agreement for a breathalyzer device.

Portfolio Pulse from Vandana Singh

August 14, 2024 | 11:30 am

ALBT

Avalon GloboCare's Laboratory Services MSO is set to launch sales of a proprietary FDA-registered external male catheter device.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:30 am

CAH

Cardinal Health shares are trading higher following the company's strong Q4 results and an upward revision of its 2025 outlook.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:20 am

FLUT

Flutter Entertainment shares are trading higher after the company reported a year-over-year increase in Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:19 am

IGMS

IGM Biosciences reported a Q2 2024 GAAP EPS of $(0.79), which is not comparable to the $0.04 estimate. The company also reported sales of $1.254 million, which is not comparable to the $54.313 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:19 am

K

Kellanova shares are trading higher following a report suggesting Mars is expected to pay $83.50 per share for the company.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 11:19 am